[ 131 l]MIBG radionuclide therapy in carcinoid syndrome

European Journal of Surgical Oncology

Volumn 28, Issue 3, 2002, Pages 243-

  Taal, B G ^a   Zuetenhorst, H ^a   Valdes Olmos, R A ^a   Hoefnagel, C A ^a  

^a ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 131; (3 IODOBENZYL)GUANIDINE; ANTINEOPLASTIC AGENT; RADIOACTIVE IODINE; RADIOPHARMACEUTICAL AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CANCER REGRESSION; CANCER SCINTISCANNING; CARCINOID SYNDROME; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DOSE RESPONSE; DRUG DISTRIBUTION; DRUG EFFECT; DRUG SAFETY; DRUG TISSUE LEVEL; EXPERIENCE; HUMAN; HUMAN TISSUE; LETTER; LIVER METASTASIS; MOUSE; NONHUMAN; PALLIATIVE THERAPY; PATIENT SELECTION; PRIORITY JOURNAL; RADIATION EXPOSURE; RADIOISOTOPE THERAPY; TOXICITY; CARCINOID; METHODOLOGY; NOTE; SCINTISCANNING; TREATMENT OUTCOME;

3-IODOBENZYLGUANIDINE; ANTINEOPLASTIC AGENTS; CARCINOID TUMOR; HUMANS; IODINE RADIOISOTOPES; PALLIATIVE CARE; RADIOPHARMACEUTICALS; TREATMENT OUTCOME;

EID: 0036527377     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1053/ejso.2001.1225     Document Type: Editorial

References (5)

1. 131 I-MIBG radionuclide therapy is safe and cost-effective in the control of symptoms of the carcinoid syndrome
2. Palliative effect of meta-iodobenzylguanidin in metastatic carcinoid tumors
3. 131 I-MIBG treatment by predosing with non-radiolabeled MIBG in carcinoid patients and studies in xenografted mice
4. 131 I-labeled MIBG and the combination
5. 131 I-MIBG uptake in carcinoid tumours by administration of unlabelled MIBG